Skip to main content
. Author manuscript; available in PMC: 2011 Jul 19.
Published in final edited form as: Depress Anxiety. 2010 Apr;27(4):351–364. doi: 10.1002/da.20634

Table 5. Twelve-month comorbidity (odds-ratios) of DSM-IV/CIDI MDE with chronic physical disorders by age1.

Age Groups Age Difference3

All Ages 18-34 35-49 50-64 65+ % OR
%2(se) OR2(CI) %2(se) OR2(CI) %2(se) OR2(CI) %2(se) OR2(CI) %2(se) OR2(CI) χ23

I. Developed
 Cardiovascular4 19.5 (1.0) 1.0(0.9-1.2) 5.8 (1.0) 2.2*(1.5-3.3) 14.1 (1.5) 1.4*(1.1-1.8) 39.4 (2.5) 1.5*(1.2-1.9) 58.0 (3.5) 1.4*(1.0-1.9) 177.9* 4.4
 Musculoskeletal4 41.2 (1.2) 1.7*(1.6-1.9) 25.1 (1.7) 2.0*(1.6-2.4) 44.3 (2.0) 2.2*(1.8-2.6) 57.0 (2.4) 2.0*(1.7-2.5) 68.7 (3.2) 2.3*(1.6-3.1) 117.6* 1.4
 Respiratory4 33.4 (1.2) 1.5*(1.4-1.7) 33.7 (1.8) 1.4*(1.1-1.6) 35.3 (1.9) 1.6*(1.3-1.9) 33.1 (2.4) 1.7*(1.4-2.2) 25.2 (3.1) 1.4(1.0-2.0) 1.9 2.3
 Pain conditions4 13.2 (0.7) 2.3*(2.0-2.7) 8.8 (1.0) 2.2*(1.6-2.8) 12.9 (1.2) 2.4*(1.9-3.1) 19.8 (2.1) 2.9*(2.2-3.9) 19.8 (2.8) 2.3*(1.5-3.4) 21.2* 1.4
 Cancer 4.0 (0.4) 0.9(0.7-1.1) 1.4 (0.3) 1.9*(1.0-3.4) 4.1 (0.8) 1.6*(1.0-2.5) 6.4 (1.2) 1.1(0.7-1.7) 9.9 (2.2) 1.1(0.6-1.8) 23.9* 7.4
 Diabetes 5.2 (0.6) 1.0(0.8-1.3) 0.9 (0.3) 1.0(0.6-1.8) 3.9 (0.8) 1.5(0.9-2.3) 10.8 (1.6) 1.3(0.9-1.8) 17.3 (3.1) 1.4(0.9-2.1) 45.4* 1.1
 Ulcers 4.2 (0.5) 2.2*(1.7-2.8) 2.6 (0.6) 2.4*(1.3-4.3) 5.2 (0.8) 2.5*(1.7-3.7) 5.5 (1.1) 2.1*(1.4-3.4) 5.7 (1.5) 1.6(0.8-2.9) 4.1 0.8
Number of disorders
 Any 71.5 (1.1) 1.9*(1.7-2.1) 61.2 (1.9) 2.0*(1.7-2.4) 73.8 (1.8) 2.4*(1.9-2.9) 81.7 (2.1) 2.1*(1.6-2.8) 87.9 (2.2) 2.0*(1.2-3.1) 55.7* 2.4
 One5 24.0 (1.0) 1.4*(1.2-1.6) 26.2 (1.7) 1.5*(1.2-1.8) 27.8 (1.8) 1.8*(1.4-2.3) 18.8 (2.0) 1.3(0.9-1.8) 11.3 (2.1) 0.8(0.5-1.5) 10.6* 9.5*
 Two5 19.6 (0.9) 1.9*(1.6-2.2) 19.6 (1.5) 2.2*(1.8-2.8) 19.3 (1.6) 2.2*(1.7-2.9) 19.3 (2.0) 1.8*(1.3-2.6) 21.1 (3.0) 1.8*(1.1-3.1) 21.6* 3.8
 Three or more5 28.0 (1.1) 2.7*(2.4-3.2) 15.5 (1.3) 3.6*(2.8-4.8) 26.7 (1.9) 3.9*(3.1-5.1) 43.6 (2.5) 3.6*(2.6-4.9) 55.6 (3.6) 3.0*(1.9-4.9) 107.8* 3.4
 (n) (2948) (1070) (982) (620) (276)
II. Developing
 Cardiovascular4 22.4 (1.0) 1.4*(1.2-1.6) 8.5 (0.9) 1.8*(1.3-2.5) 23.8 (2.4) 1.4*(1.1-1.9) 50.0 (3.1) 1.5*(1.1-2.0) 66.5 (3.7) 1.8*(1.2-2.7) 93.7* 1.3
 Musculoskeletal4 43.2 (1.7) 2.2*(1.9-2.6) 33.3 (2.6) 2.7*(2.1-3.5) 46.8 (2.8) 2.2*(1.8-2.8) 57.2 (3.0) 1.5*(1.1-2.1) 75.8 (3.5) 2.3*(1.5-3.6) 24.0* 8.4*
 Respiratory4 21.6 (1.4) 1.7*(1.4-2.1) 20.2 (2.7) 1.7*(1.2-2.6) 22.6 (2.4) 1.7*(1.2-2.2) 22.9 (3.2) 1.6*(1.0-2.3) 25.7 (4.8) 1.8*(1.1-2.9) 1.8 0.5
 Pain conditions 19.5 (1.3) 2.4*(2.0-2.9) 15.1 (1.6) 2.7*(2.1-3.6) 21.3 (2.1) 2.4*(1.8-3.2) 25.9 (2.6) 2.1*(1.5-2.9) 32.4 (5.2) 2.2*(1.3-3.8) 0.9 1.5
 Cancer 0.8 (0.2) 1.0(0.5-1.8) 0.5 (0.4) -(-,-)5 0.5 (0.3) 0.9(0.3-2.9) 1.6 (0.6) 0.9(0.4-2.2) 2.7 (1.0) 1.2(0.6-2.8) 9.4* 8.9*
 Diabetes 5.0 (0.6) 1.3(1.0-1.7) 0.9 (0.3) 1.2(0.6-2.5) 5.9 (1.3) 1.6(0.9-2.7) 13.4 (2.2) 1.4(1.0-2.1) 14.8 (4.4) 1.5(0.7-2.9) 37.2* 2.2
 Ulcers 9.0 (0.8) 2.4*(1.9-3.0) 4.9 (0.9) 2.0*(1.3-3.0) 14.0 (2.1) 3.3*(2.2-4.8) 12.2 (2.4) 2.3*(1.4-3.7) 12.0 (2.5) 1.8(1.0-3.4) 12.4* 5.0
Number of disorders
 Any 72.0 (1.3) 2.6*(2.2-3.0) 63.6 (2.3) 3.0*(2.3-3.8) 76.7 (2.3) 2.5*(1.9-3.2) 84.7 (2.2) 2.0*(1.4-2.9) 89.2 (2.7) 1.5(0.8-2.8) 20.6* 4.4
 One5 22.1 (1.5) 1.7*(1.4-2.0) 26.6 (2.4) 2.1*(1.5-2.7) 20.9 (2.3) 1.5*(1.0-2.0) 15.0 (2.2) 1.2(0.8-1.9) 8.0 (2.4) 0.6(0.2-1.4) 3.6 11.6*
 Two5 19.6 (1.4) 2.5*(2.0-3.0) 19.0 (2.3) 3.0*(2.2-4.1) 22.7 (2.3) 2.3*(1.6-3.3) 18.8 (2.9) 1.9*(1.1-3.3) 10.5 (2.8) 0.7(0.3-1.5) 5.3 9.9*
 Three or more5 30.3 (1.7) 4.7*(3.8-5.8) 18.1 (2.3) 7.5*(5.3-10.8) 33.1 (2.8) 4.2*(3.0-6.0) 50.9 (3.4) 3.2*(2.0-5.0) 70.7 (4.0) 2.2*(1.1-4.4) 31.7* 8.2*
 (n) (2231) (877) (716) (440) (198)
*

Significant at the .05 level, two-sided test

1

The results in this table are based on a series of multivariate logistic regression equations in which a dichotomous predictor for a single 12-month comorbid disorder was used to predict a dichotomous measure of 12-month MDE controlling for respondent sex, education and marital status.

2

Entries in the % columns represent the conditional prevalence estimate (and standard error of that estimate) of each    comorbid disorder among respondents with 12-month MDE. Entries in the OR columns represent the odds-ratio (OR) and 95% Confidence Interval (95% CI) of the OR between MDE and the comorbid disorder estimated in the logistic regression equation.

3

The χ2 tests in the Age Differences columns test the statistical significance of age differences in conditional prevalence of the comorbid disorders among respondents with MDE (%) and of the ORs between MDE and the comorbid disorders (OR).

4

Cardiovascular conditions include heart attack, hypertension, other heart disease, stroke; musculoskeletal conditions include arthritis/rheumatism, chronic back/neck problems; respiratory conditions include seasonal allergies, asthma, other chronic lung disease such as chronic obstructive pulmonary disorder and tuberculosis; pain conditions include frequent/severe headaches, other chronic pain conditions

5

The ORs associated with number of comorbid disorders are based on a single equation in each age group to predict 12-month MDE from three dichotomies for one, two, and three or more comorbid disorders in comparison to the contrast category of no such disorders. As with the other equations, controls were included for sex, education and marital status.